Serum cholesterol levels and the risk of Parkinson's disease

被引：165
作者：
de lau, Lonneke M. L.
Koudstaal, Peter J.
Hofman, Albert
Breteler, Monique M. B.
机构：
[1] Erasmus MC, Dept Epidemiol & Biostat, NL-3000 DR Rotterdam, Netherlands
[2] Erasmus MC, Dept Neurol, NL-3000 DR Rotterdam, Netherlands
来源：
AMERICAN JOURNAL OF EPIDEMIOLOGY | 2006年 / 164卷 / 10期
关键词：
cholesterol; cohort studies; lipid metabolism; neurodegenerative diseases; Parkinson disease; prospective studies; risk factors; serum;
D O I：
10.1093/aje/kwj283
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
Several recent findings suggest a role of lipid and cholesterol metabolism in the pathogenesis of Parkinson's disease. Therefore, the authors examined the association between serum levels of cholesterol and the risk of Parkinson's disease in the prospective, population-based Rotterdam Study among 6,465 subjects aged 55 or more years with repeated in-person examination and on average 9.4 years of follow-up (1990-2004). Higher serum levels of total cholesterol were associated with a significantly decreased risk of Parkinson's disease (age- and sex-adjusted hazard ratio per mmol/liter increase in cholesterol = 0.77, 95% confidence interval: 0.64, 0.94), with evidence for a dose-effect relation. The association was restricted to women and remained unchanged after adjustment for multiple potential confounders. These findings may indicate a role of lipids in the pathogenesis of Parkinson's disease. Alternatively, they could reflect the strong correlation-especially in women-between levels of serum cholesterol and the antioxidant coenzyme Q10. If confirmed, this would provide further support for an important role of oxidative stress in the pathogenesis of Parkinson's disease.
引用
收藏
页码：998 / 1002
页数：5
相关论文
共 23 条
[1]   Environmental, life-style, and physical precursors of clinical Parkinson's disease: recent findings from the Honolulu-Asia Aging Study [J].
Abbott, RD ;
Ross, GW ;
White, LR ;
Sanderson, WT ;
Burchfiel, CM ;
Kashon, M ;
Sharp, DS ;
Masaki, KH ;
Curb, JD ;
Petrovitch, H .
JOURNAL OF NEUROLOGY, 2003, 250 (Suppl 3) :30-39
[2]   Coenzyme Q10 attenuates the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) induced loss of striatal dopamine and dopaminergic axons in aged [J].
Beal, MF ;
Matthews, RT ;
Tieleman, A ;
Shults, CW .
BRAIN RESEARCH, 1998, 783 (01) :109-114
[3]   Dietary fatty acids and the risk of Parkinson disease - The Rotterdam study [J].
de Lau, LML ;
Bornebroek, M ;
Witteman, JCM ;
Hofman, A ;
Koudstaal, PJ ;
Breteler, MMB .
NEUROLOGY, 2005, 64 (12) :2040-2045
[4]   Incidence of parkinsonism and Parkinson disease in a general population - The Rotterdam Study [J].
de Lau, LML ;
Giesbergen, PCLM ;
de Rijk, MC ;
Hofman, A ;
Koudstaal, PJ ;
Breteler, MMB .
NEUROLOGY, 2004, 63 (07) :1240-1244
[5]   Lipid rafts mediate the synaptic localization of α-synuclein [J].
Fortin, DL ;
Troyer, MD ;
Nakamura, K ;
Kubo, S ;
Anthony, MD ;
Edwards, RH .
JOURNAL OF NEUROSCIENCE, 2004, 24 (30) :6715-6723
[6]   A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease [J].
Hernán, MA ;
Takkouche, B ;
Caamaño-Isorna, F ;
Gestal-Otero, JJ .
ANNALS OF NEUROLOGY, 2002, 52 (03) :276-284
[7]   APOE-ε2 allele associated with higher prevalence of sporadic Parkinson disease [J].
Huang, XM ;
Chen, PC ;
Poole, C .
NEUROLOGY, 2004, 62 (12) :2198-2202
[8]   Coffee consumption and serum lipids: A meta-analysis of randomized controlled clinical rials [J].
Jee, SH ;
He, J ;
Appel, LJ ;
Whelton, PK ;
Suh, I ;
Klag, MJ .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2001, 153 (04) :353-362
[9]   Determinants of plasma coenzyme Q10 in humans [J].
Kaikkonen, J ;
Nyyssönen, K ;
Tuomainen, TP ;
Ristonmaa, U ;
Salonen, JT .
FEBS LETTERS, 1999, 443 (02) :163-166
[10]   Coenzyme Q10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects [J].
Matthews, RT ;
Yang, LC ;
Browne, S ;
Baik, M ;
Beal, MF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (15) :8892-8897
123